An Oral Glucose Tolerance Test in Pregnancy Can Serve as a Valuable Predictor for Future Diabetes
The Journal of Clinical Endocrinology & Metabolism · 2026
DOI: 10.1210/clinem/dgaf534 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Tal Schiller und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Endocrinology, Diabetes and Metabolic Disease, Wolfson Medical Center, Gray Faculty of Medical and Health Sciences, Tel Aviv University,…. Hauptthemen laut MEDLINE: Diabetes, Gestational, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Marom.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Adherence to screening following a pregnancy with gestational diabetes mellitus (GDM) remains low.
Objective
To assess the risk of future type 2 diabetes (T2D) based on the number and type of abnormal results of a 100-gram oral glucose tolerance test (OGTT) performed during pregnancy.
Methods
This retrospective study used data from a major Israeli healthcare provider. Women aged 20 to 50 years without a prior diagnosis of T2D who had a complete 100-gram OGTT during their last pregnancy between January 2000 and December 2022 were included. The primary outcome was the development of T2D by September 2024. Risk was assessed using Cox proportional hazards models based on the number and type of abnormal OGTT values.
Results
The study included 107 889 women (age 34.1 ± 5.2 years; BMI 27.6 ± 5.3 kg/m2). Median follow-up was 6.7 years (IQR 3.3-12.4), totaling 900 000 person-years. T2D developed in 4500 women (0.5%). When compared to women with all OGTT values normal, the risk of T2D rose with each additional abnormal value: hazard ratio (HR) 3.45 (95% CI: 3.15-3.77) for 1 abnormal value, 4.03 (3.69-4.41) for 2 abnormal values, 7.15 (6.49-7.88) for 3, and 10.60 (9.28-12.20) for 4. Abnormal fasting glucose was associated with a higher risk (HR 5.28; 95% CI: 4.83-5.76) than abnormal nonfasting values (HR 3.03; 95% CI: 2.78-3.29). A previous diagnosis of GDM was significantly associated with future T2D risk, even in patients with no current abnormal OGTT values.
Conclusion
The number and type of abnormal OGTT results strongly predict future T2D. These findings can inform targeted postpartum interventions and predictive tools for early prevention in high-risk women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Endocrinology, Diabetes and Metabolic Disease, Wolfson Medical Center, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 58100, Israel.
- Kahn-Sagol-Maccabi Research and Innovation Institute, Maccabi Healthcare Services, Tel Aviv 6812509, Israel.
- Department of Obstetrics and Gynecology, Kaplan Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 7661041, Israel.
- Department of Internal Medicine A, Kaplan Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 7661041, Israel.
- Department of Cardiology, Kaplan Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 7661041, Israel.
- School of Public Health, Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.
ORCID-Profile: Tal Schiller, Alena Kirzhner
Förderung
- Marom
Zitieren
APA
Schiller, T., Gabay, L., Barak, O., Kirzhner, A., Abu Khadija, H., Chodick, G., Vaisbuch, E., & Barer, Y. (2026). An Oral Glucose Tolerance Test in Pregnancy Can Serve as a Valuable Predictor for Future Diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf534
Vancouver
Schiller T, Gabay L, Barak O, Kirzhner A, Abu Khadija H, Chodick G, et al. An Oral Glucose Tolerance Test in Pregnancy Can Serve as a Valuable Predictor for Future Diabetes. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf534
BibTeX
@article{Schiller2026,
author = {Schiller, Tal and Gabay, Linoy and Barak, Oren and Kirzhner, Alena and Abu Khadija, Haitham and Chodick, Gabriel and Vaisbuch, Edi and Barer, Yael},
title = {An Oral Glucose Tolerance Test in Pregnancy Can Serve as a Valuable Predictor for Future Diabetes},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgaf534}
}
EUVIMED